Session One Faculty Includes
How a LAB Cohort Works
SCRS Site Insight Labs bring sponsor, CRO, and solution-provider teams together with experienced clinical research site leaders to address specific operational needs. Through SCRS-led discussions, LABs provide private working sessions where your team can gain direct site feedback, recommended actions, and clear goals to advance site-facing programs within your organization.
2027 LAB Cohorts include:
Startup is the most controllable variable in your timeline
Delays between site selection and first patient screened are rarely caused by sites alone. They are caused by decisions upstream — and most of those decisions belong to sponsors and CROs.
Most organizations know startup is broken. Few have a structured way to hear from sites exactly which of their own decisions are making it worse.
WHERE ACTIVATION STALLS
Information gaps — feasibility packages that leave sites guessing at what the protocol will actually demand.
Budget and contract friction — negotiation cycles that add weeks before a single patient is screened.
System access failures — credentials, training, and portal access that arrive after the site is ready to work.
Communication breakdowns — unclear ownership between sponsor, CRO, and site during the handoff window.
Investment
Enrollment is limited to preserve the quality and intimacy of each private session. The Lab 1 pilot begins January 2027.
LAB PIPELINE
Labs launch one at a time
Topics are identified and validated by SCRS from Landscape Survey data, Eagle Award category performance, and GIP satisfaction signals. Each topic is scoped to a specific, actionable sub-question before the Lab opens. The sequence is a recommendation, not a commitment.
Questions partners ask first:
Do you need a custom Site Focus Group?
SCRS will work with your organization to build a customized, site-centered engagement that delivers
practical insight and strengthens collaboration across the clinical research ecosystem.





